Personal information

tumor signal transduction
China

Activities

Employment (2)

The First Hospital of China Medical University: Shenyang, Liaoning, CN

2021-08-01 to present | Associate Professor (Medical Oncology)
Employment
Source: Self-asserted source
Tao Han

General Hospital of Shenyang Military Command: Shenyang, Liaoning Province, CN

2013-07 to 2021-08-01 | Attending physician (Department of Oncology)
Employment
Source: Self-asserted source
Tao Han

Education and qualifications (3)

Second Military Medical University: Shanghai, CN

2010-09 to 2013-06 | MD Degree
Education
Source: Self-asserted source
Tao Han

Second Military Medical University: Shanghai , CN

2008-09 to 2010-06 | MM Degree
Education
Source: Self-asserted source
Tao Han

Chinese Medical University: Shenyang, Liaoning Province, CN

2003-09 to 2008-06 | MB Degree
Education
Source: Self-asserted source
Tao Han

Funding (3)

Regulation of Shp2 mediated activation of HIF-1a expression and its clinical significance in predicting chemosensitivity of breast cancer stem cells in TNBC

2018-01 to 2020-12 | Grant
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Tao Han

Effect of protein tyrosine phosphatase Shp2 on the effect of liver cancer stem cells on the development of liver cancer

2015-10 to 2018-10 | Grant
Natural Science Foundation of Liaoning Province (Shenyang, CN)
Source: Self-asserted source
Tao Han

Regulation of the progression of Hepatocellular carcinoma and related Clinical Research

2014-01 to 2016-12 | Grant
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Tao Han

Works (25)

Emerging advances in drug delivery systems (DDSs) for optimizing cancer complications

Materials Today Bio
2025-02 | Journal article
Contributors: Kerui Li; Bei Guo; Junmou Gu; Na Ta; Jia Gu; Hao Yu; Mengchi Sun; Tao Han
Source: check_circle
Crossref

Circulating tumor DNA: current implementation issues and future challenges for clinical utility

Clinical Chemistry and Laboratory Medicine (CCLM)
2024-10-28 | Journal article
Contributors: Qilin Hu; Lujun Chen; Kerui Li; Ruotong Liu; Lei Sun; Tao Han
Source: check_circle
Crossref

miR-3154 promotes hepatocellular carcinoma progression via suppressing HNF4α

Carcinogenesis
2022-11-23 | Journal article
Contributors: Yuan Wei; Lai Wei; Tao Han; Shuang Ding
Source: check_circle
Crossref

miR-3168 promotes hepatocellular carcinoma progression via downregulating p53

Carcinogenesis
2022-11-23 | Journal article
Contributors: Tingting Lu; Tao Han; Mingfang Zhao
Source: check_circle
Crossref

Identification of the Mechanism of Matrine Combined with Glycyrrhizin for Hepatocellular Carcinoma Treatment through Network Pharmacology and Bioinformatics Analysis

Oxidative Medicine and Cellular Longevity
2022-09-19 | Journal article
Contributors: Tao Han; Yiming Liu; Yutong Chen; Tingsong Chen; Yifan Li; Qiuhua Li; Mingfang Zhao; Abdur Rauf
Source: check_circle
Crossref

Downregulation of MUC15 by miR-183-5p.1 promotes liver tumor-initiating cells properties and tumorigenesis via regulating c-MET/PI3K/AKT/SOX2 axis.

Cell death & disease
2022-03-02 | Journal article
Source: Self-asserted source
Tao Han

HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.

Journal of hematology & oncology
2022-01-06 | Journal article
Source: Self-asserted source
Tao Han

Construction of a ceRNA network in hepatocellular carcinoma and comprehensive analysis of immune infiltration patterns.

American journal of translational research
2021-12-15 | Journal article
Source: Self-asserted source
Tao Han

Comprehensive Analysis of Inflammatory Response-Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma.

Frontiers in pharmacology
2021-10-12 | Journal article
Source: Self-asserted source
Tao Han

Prediction of Poor Prognosis of HCC by Early Warning Model for Co-Expression of miRNA and mRNA Based on Bioinformatics Analysis

Technology in Cancer Research & Treatment
2020-01-01 | Journal article
Contributors: Zi-jian Su; Chun-cheng Lin; Jian-hui Pan; Jian-hua Zhang; Tao Han; Qunxiong Pan
Source: check_circle
Crossref

MicroRNA-28-5p Regulates Liver Cancer Stem Cell Expansion via IGF-1 Pathway.

Stem cells international
2019-12 | Journal article
Contributors: Xia Q; Han T; Yang P; Wang R; Li H; Zhang J; Zhou X
Source: Self-asserted source
Tao Han via Europe PubMed Central

miR-552 promotes ovarian cancer progression by regulating PTEN pathway.

Journal of ovarian research
2019-12 | Journal article
Contributors: Zhao W; Han T; Li B; Ma Q; Yang P; Li H
Source: Self-asserted source
Tao Han via Europe PubMed Central

Hepatocellular carcinoma with pancreatic mass as the first symptom: a case report and literature review.

Annals of palliative medicine
2019-11 | Journal article
Contributors: Zhang Y; Han T; Wang D; Li G; Zhang Y; Yang X; Chen T; Zheng Z
Source: Self-asserted source
Tao Han via Europe PubMed Central

The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis.

Bioscience trends
2019-10 | Journal article
Contributors: Han T; Yang X; Zhang Y; Li G; Liu L; Chen T; Zheng Z
Source: Self-asserted source
Tao Han via Europe PubMed Central

Successful treatment of relapsed testicular embryonal rhabdomyosarcoma with Endostar and traditional chemotherapy: a case report.

OncoTargets and therapy
2018-08 | Journal article
Contributors: Han T; Chen J; Luan Y; Chen X; Yang X; Zhang Y; Li G; Wang D; Zheng Z
Source: Self-asserted source
Tao Han via Europe PubMed Central

Association Between Hepatocellular Carcinoma and Type 2 Diabetes Mellitus in Chinese Hepatitis B Virus Cirrhosis Patients: A Case-Control Study.

Medical science monitor : international medical journal of experimental and clinical research
2017-07 | Journal article
Contributors: Han H; Deng H; Han T; Zhao H; Hou F; Qi X
Source: Self-asserted source
Tao Han via Europe PubMed Central

Successful treatment of advanced pancreatic liposarcoma with apatinib: A case report and literature review.

Cancer biology & therapy
2017-07 | Journal article
Contributors: Han T; Luan Y; Xu Y; Yang X; Li J; Liu R; Li Q; Zheng Z
Source: Self-asserted source
Tao Han via Europe PubMed Central

Therapeutic value of 3-D printing template-assisted 125I-seed implantation in the treatment of malignant liver tumors.

OncoTargets and therapy
2017-07 | Journal article
Contributors: Han T; Yang X; Xu Y; Zheng Z; Yan Y; Wang N
Source: Self-asserted source
Tao Han via Europe PubMed Central

Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3.

International journal of molecular sciences
2017-01 | Journal article
Contributors: Qi C; Han T; Tang H; Huang K; Min J; Li J; Ding X; Xu Z
Source: Self-asserted source
Tao Han via Europe PubMed Central

Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
2015-08 | Journal article
Contributors: Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF
Source: Self-asserted source
Tao Han via Europe PubMed Central

High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer.

OncoTargets and therapy
2015-07 | Journal article
Contributors: Han T; Liu Z; Li H; Xie W; Zhang R; Zhu L; Guo F; Han Y; Sheng Y; Xie X
Source: Self-asserted source
Tao Han via Europe PubMed Central

Lambert-Eaton myasthenic syndrome in a patient with small-cell lung cancer: A case report.

Oncology letters
2015-07 | Journal article
Contributors: Zhang RR; Han T; Guo F; Liu ZZ; Han YL; Chen WC; Liu YY; Xie XD
Source: Self-asserted source
Tao Han via Europe PubMed Central

PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.

Journal of hepatology
2015-04 | Journal article
Contributors: Han T; Xiang DM; Sun W; Liu N; Sun HL; Wen W; Shen WF; Wang RY; Chen C; Wang X et al.
Source: Self-asserted source
Tao Han via Europe PubMed Central

SHP2 promotes laryngeal cancer growth through the Ras/Raf/Mek/Erk pathway and serves as a prognostic indicator for laryngeal cancer.

International journal of oncology
2013-11 | Journal article
Contributors: Gu J; Han T; Ma RH; Zhu YL; Jia YN; Du JJ; Chen Y; Jiang XJ; Xie XD; Guo X
Source: Self-asserted source
Tao Han via Europe PubMed Central

Cyclin G1 expands liver tumor-initiating cells by Sox2 induction via Akt/mTOR signaling.

Molecular cancer therapeutics
2013-06 | Journal article
Contributors: Wen W; Han T; Chen C; Huang L; Sun W; Wang X; Chen SZ; Xiang DM; Tang L; Cao D et al.
Source: Self-asserted source
Tao Han via Europe PubMed Central